Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Burden of vaso-occlusive crisis, its management and impact on quality of life of Indian sickle cell disease patients.
Seth T, Udupi S, Jain S, Bhatwadekar S, Menon N, Jena RK, Kumar R, Ray S, Parmar B, Goel AK, Vasava A, Dutta A, Samal P, Ballikar R, Bhat D, Dolai TK, Bhattacharyya J, Shetty D, Mistry M, Jain D. Seth T, et al. Among authors: goel ak. Br J Haematol. 2024 Oct 28. doi: 10.1111/bjh.19829. Online ahead of print. Br J Haematol. 2024. PMID: 39463175
A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients With Solid Malignancies: A Phase IV, Post-Marketing Study in India.
Sinha SD, Biswas G, Bheemareddy BR, Chary S, Thakur P, Jain M, Maksud T, Pawar S, Chatterjee K, Voonna MK, Goel A, Puligundla KC, Lakshmaiah KC, Talluri L, Vattipalli R, Kakkunnath S. Sinha SD, et al. Cancer Inform. 2023 Jun 1;22:11769351231177277. doi: 10.1177/11769351231177277. eCollection 2023. Cancer Inform. 2023. PMID: 37313371 Free PMC article.
A Randomized, Double-Blind, Phase III Study in India for Comparing Efficacy, Safety, and PK of ZRC-3277 (Pertuzumab Biosimilar) With Perjeta® in Patients With HER2-Positive Metastatic Breast Cancer.
Kothari R, Doshi M, Chaithanya PK, Ct S, Kumar A, Mallavarapu KM, Nagarkar R, Mahobia V, Bhatt N, Priyadarshini KL, Gogia A, Maksud T, Prasad S, Velavan K, L K R, Ss P, Talreja V, Kalra K, Nemade B, Dastidar AG, Gupta T, Patil T, Bondarde S, Patel P, Gupta S, Biswas G, Vaghela M, Mahato P, Parekh H, Kalloli M, Shetty R, Prakash G, Goel A, Mandal S, Choudhury T, Jain M, Goswami C, H M YK, Mukherjee KK, Shrivastava R, Parmar D. Kothari R, et al. Clin Breast Cancer. 2024 Oct;24(7):639-646.e2. doi: 10.1016/j.clbc.2024.07.001. Epub 2024 Jul 10. Clin Breast Cancer. 2024. PMID: 39069436 Clinical Trial.
Leaving Against Medical Advice From Children's Hospitals.
Campbell JI, Tolliver DG, He Y, Wang RY, Shapiro J, Shanahan K, Mell A, Luercio M, Shah SN, Hall M, Goel AK, Melvin P, Ward VL, Berry J. Campbell JI, et al. Among authors: goel ak. Pediatrics. 2024 Nov 1;154(5):e2023064958. doi: 10.1542/peds.2023-064958. Pediatrics. 2024. PMID: 39380538
Lipid-nanoparticle-enabled nucleic acid therapeutics for liver disorders.
Arjunan P, Kathirvelu D, Mahalingam G, Goel AK, Zacharaiah UG, Srivastava A, Marepally S. Arjunan P, et al. Among authors: goel ak. Acta Pharm Sin B. 2024 Jul;14(7):2885-2900. doi: 10.1016/j.apsb.2024.04.015. Epub 2024 Apr 22. Acta Pharm Sin B. 2024. PMID: 39027251 Free PMC article. Review.
209 results